Corporate
The doctor in the death-bed
THE irony of it all cannot be missed even if it means a casual reading of one of the performance reviews of the sick companies' ``doctor,'' the Board for Industrial and Financial Reconstruction (BIFR).

Mutual Funds
Old-economy stocks back in reckoning
WORDS, words, words. Last week, there was a surfeit of that from the stock markets, and equity funds had little to show for themselves save some plain adjustments in their portfolios. Going by indications, this week may not be any different.

Stocks
Light at the end of tunnel?
THE uncertainty is likely to give way and the market may step into a consolidation phase in the week ahead, gaining direction in the process.

Page One | Index | Home